Industry hub: Healthcare & Life Sciences · Contracts: Business & contract · Product risk: Product liability lawyers · Data: PIPL.
What usually counts as “advertising / promotion”
- TV, print, outdoor, and paid online ads
- WeChat official accounts, Douyin/Kuaishou, Bilibili, e-commerce product pages, mini-programs
- KOL/doctor endorsements, hospital meeting sponsorships with product pitches
- Brochures, booth claims, “educational” content that steers purchase of a specific device
If it names or implies a registrable device and drives selection/purchase, treat it as regulated promotion until counsel says otherwise.
Claims, indications, and evidence
- Stick to the registered scope — indications, intended use, and contraindications in the registration/filing documents bound marketing claims.
- No absolute or guarantee language — “100% safe,” “cures,” “best,” “the only,” miracle narratives.
- Clinical / performance data — only use data you can substantiate; translate carefully; do not extrapolate off-label.
- Comparisons — high risk without rigorous, fair basis and legal review.
- Patient testimonials — often restricted or impractical for devices; get specialist review before any human story.
Channel-specific friction
| Channel | Watch-outs |
|---|---|
| E-commerce detail pages | Claim creep vs registration; fake reviews; unauthorized sellers diluting compliance |
| KOL / livestream | Script control, side claims, gift promotions, medical advice appearance |
| Academic meetings | Blurred line between science exchange and product ads; sponsorship disclosures |
| Cross-border e-commerce | Import channel limits; claims still scrutinised; see e-com hub |
| Global English site geo-visible in China | May still be reached by China users—align or geo-filter |
Internal control process (recommended)
- Claim library locked to registration texts (Chinese master).
- Marketing, medical, and legal sign-off workflow before publish.
- Agency/KOL contracts with claim scripts, takedown rights, indemnities.
- Archive of approved creatives and versions.
- Complaint and regulator inquiry response owner.
- Align privacy notices if campaigns collect health-related PI (PIPL).
Pre-launch checklist
- [ ] Device registration/filing status confirmed for the SKU promoted
- [ ] Chinese claim list matches approved IFU/registration language
- [ ] No superlatives / cure guarantees / unapproved indications
- [ ] Channel list approved (including KOLs and e-com)
- [ ] Agency/KOL contracts signed with script control
- [ ] Medical + legal sign-off recorded
- [ ] Adverse event / complaint path briefed to support teams
- [ ] Unauthorized distributor monitoring plan
Common mistakes
- Translating global ads without localisation to Chinese registration scope.
- Letting KOLs improvise clinical claims on livestream.
- Promoting a pipeline product as if already approved.
- Ignoring offline hospital materials that sales reps still use.
Counsel & next
Healthcare hub Product liability lawyers Contract lawyers Find counsel
General information only—not advertising approval advice. Device advertising and registration rules are technical and change. Engage specialised PRC counsel before campaigns. Last reviewed: August 2026 · China Legal Portal Editorial
